Filter by:
Category
Category
- All categories
- Advances for Medical Professionals
- Medical News for Patients & Visitors
- NYP News
- Outcomes & Quality Reports
Specialty
Specialty
- All specialties
Type
Type
- All types
- Clinical innovations
- Newsletter
- Research
Years
Years
- All years
Locations
Locations
- All locations
Filtered by:
-
Advances for Medical Professionals Close Advances for Medical Professionals filter
- Clear All
Urology
Single-Cell Analysis Links Immune Cells to Kidney Cancer Recurrence
Columbia University faculty present research on a previously unknown type of immune cell in kidney tumors that can predict which patients are likely to have cancer recur after surgery.
Psychiatry
Ketamine: The Benefits Continue to Unfold
Columbia University and Weill Cornell Medicine psychiatrists continue to investigate – in the clinic and in the lab – the potential role of ketamine in the treatment of resistant depression.
Pulmonology
Cystic Fibrosis: A Paradigm Treatment Shift is Underway
Columbia University pulmonologists conducts clinical trial on novel triple combination modulator for cystic fibrosis in patients with advanced lung disease, demonstrating progressive improvement in weight, lung function, and patient-reported outcomes.
Ophthalmology
First-of-Its-Kind Gene Therapy Trials for Dry AMD
Columbia University is one of the leading programs in the United States conducting a groundbreaking Phase 2 clinical trial of an investigational gene therapy for dry age-related macular degeneration.
Gynecology
Augmenting Understanding of SARS-CoV-2 in Pregnancy
NewYork-Presbyterian obstetricians and gynecologists continue to investigate COVID-19 and its potential impact on pregnancy outcomes, including studies on serial testing for SARS-CoV-2 and
vaccinations.
Neurology
Furthering Awareness in Recovery of Consciousness
Neurologists and critical care medicine specialists at NewYork-Presbyterian Hospital offer highly specialized expertise in disorders of consciousness to promote the best outcomes for patients.
Oncology
From COVID Screening to Cancer Outcomes: Scientific Investigations Address COVID-19 and Cancer
Oncologists and other specialists at NewYork-Presbyterian Hospital continue to contribute their expertise and resources to scientific investigations of COVID-19 and its implications for oncology care.
Rheumatology
Cancer and Autoimmune Disease: Investigating the Double Duty of T Cells
Research by Adam Mor, MD, PhD, a rheumatologist and molecular immunologist at NewYork-Presbyterian/Columbia University Irving Medical Center, focuses on the function of T lymphocytes in autoimmune disease and cancer
Page4 of 30